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Comparative studies on the thermostability of five strains of
transmissible-spongiform-encephalopathy agent
Karen Fernie, Philip J. Steele1, David M. Taylor2 and Robert A. Somerville3
Neuropathogenesis Unit, Institute for Animal Health, West Mains Road, Edinburgh EH9 3JF, Scotland, U.K.
The causal infectious agents of TSEs (transmissible
spongiform encephalopathies or prion diseases) are
renowned for their resistance to complete inactivation.
Survival of TSE infectivity after autoclaving potentially
compromises many procedures where TSE infectivity
may be present, including surgical instrument steril-
ization. In the present study, the heat inactivation
properties of five different TSE agents were tested in a
variety of experiments by exposing them to a range of
heat inactivation conditions. Although TSE infectivity
was reduced after heating to 200 ◦C in a hot air oven,
substantial amounts of infectivity remained. Unlike wet
heat inactivation, no TSE strain-dependent differences
were observed in the reduction in the amounts of
infectivity produced by dry heat inactivation. However,
the incubation periods of mice infected with one dry
heated TSE strain, ME7, were substantially prolonged,
whereas there was little or no effect for two other TSE
models. Varying autoclaving conditions for three
TSE strains between 132 and 138 ◦C, and times of expo-
sure between 30 and 120 min, had little or no effect
on the recovery of TSE infectivity. The results illustrate
the limitations of TSE agent inactivation using heat-
based methods. The results support the hypothesis
that the structures of TSE agents are stabilized during
heat-inactivation procedures, rendering them much
more refractory to inactivation. This may occur
through dehydration of the causal agents, specific-
ally through the removal of the water of solvation
from agent structures and hence stabilize interactions
between prion protein and TSE agent-specific ligands.
Introduction
The TSEs (transmissible spongiform encephalopathies) are
a group of infectious diseases that include scrapie in sheep
and goats, BSE (bovine spongiform encephalopathy), chronic
wasting disease in three species of North American deer
and various forms of Creutzfeldt–Jakob disease in humans.
The structure of the causal agent has yet to be determined
[1]. The virino hypothesis suggests a two-component model
for the agent, in which a host-independent informational
molecule binds to and is protected by a host protein,
probably PrP (prion protein) [2]. Diversity in the intrinsic
thermostability properties of different TSE strains also
suggests that they must contain at least two structurally
dissimilar components. According to the virino hypothesis,
one of the components is predicted to be structurally inde-
pendent of the host and to vary in structure between TSE
strains, while the other is likely to comprise dimers or higher
multimers of the host protein, PrP [3]. By contrast, the prion
hypothesis proposes that a single host-encoded protein PrP
alters its conformation and becomes infectious [4].
The inactivation of TSE infectivity has been notoriously
difficult. Although heat inactivation can be effective at
destroying all TSE infectivity under optimal experimental
conditions [5], in many cases residual infectivity can be
recovered [6–8] and may compromise routine sterilization
procedures. Dry heat treatments are less effective than
steam heat [9]. When a series of five TSE strains each
passaged in two mouse PrP genotypes were autoclaved,
there were wide variations in the degree to which infectivity
was reduced, depending on strain of the agent, but with little
effect caused by variation of PrP genotype [10]. In some, but
not all cases, heated samples had considerably prolonged
incubation periods when compared with unheated control
samples with the same dose of TSE infectivity [10–12]. Here,
we report results from experiments in which heat inactiv-
ation has been carried out under various conditions. They
were not originally planned as a comparative series, but were
performed over several years to test various theoretical
and practical aspects of TSE agent inactivation with heat.
Conditions for experiments to test the efficacy of porous
load and gravity displacement autoclaving (Tables 2 and 3)
were chosen which reflected those used in practice and to
provide a reasonable worst-case challenge to the system, as
understood at the time the experiments were set up. It was
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possible to vary the conditions, as the machines allowed,
to see whether improvements could be recommended.
Other experiments were designed to test other aspects
of heat inactivation. The collated results demonstrate the
limitations of heat inactivation processes to destroy TSE
infectivity and are consistent with a model in which ‘fixation’
of the proteinaceous component of the agent is correlated
with resistance to inactivation. Although the ‘fixation’ of
proteins can involve the loss of essential water molecules,
it will be argued later that this might even occur during
autoclaving, where there is an abundant presence of water. If
TSE agents are fully hydrated, inactivation is thought to occur
via a denaturation reaction that is TSE strain-dependent
[3]. However, after dehydration, the denaturation reaction
may not proceed and TSE agent inactivation can only take
place through methods that destroy biological molecules.
Inactivation may only occur at higher temperatures and
with different kinetics through the chemical destruction of
components of the agent [1], which are only effective under
extreme conditions and show no TSE strain specificity.
Materials and methods
Tissue sources
Rodent passaged TSE strains were further passaged, with
strain 263K in LVG hamsters, ME7 in SV mice, and 301V
and 22A in VM mice [VM mice carry the Prnpbb (Sincp7p7) and
congenic equivalent SV mice carry the Prnpaa (Sincs7s7) allele
of the PrP gene]. When signs of TSE infection had reached a
defined end point [13], animals were killed, brains removed
and frozen at −20 ◦C. Cow BSE brain was from a field case
of BSE, generously provided by the Veterinary Laboratories
Agency (Weybridge, Surrey, U.K.). Brains were macerated
with numerous scalpel cuts to obtain a uniform consistency
or homogenized as 10% saline suspensions in Griffiths tubes.
Heat treatment of samples
Dry heat exposure was performed in a Gallenkamp Hotbox
oven. For each TSE strain, three samples of 7–10 mg of
macerate were weighed on to sterile glass slides and placed
into preheated sterile glass Petri dishes. Samples were
heated for 20 or 60 min after the oven returned to 200 +−
2 ◦C. Samples were rehydrated before injection into animals
by placing dental plugs soaked in sterile water in the Petri
dishes overnight.
For the autoclaving experiments, 50 or 375 mg samples
of TSE-infected brain macerate were placed within the
grinding area of Griffiths tubes. The tubes were angled to
face away from each other to minimize risks of cross-con-
tamination. Autoclaving was performed in a Motoclave
porous-load autoclave (British Sterilizer Co., Hainault,
Essex, U.K.). To ensure that the autoclave was performing
efficiently, the experiments in Table 2 were independently
monitored by the Common Services Agency (now Scottish
Healthcare Supplies, Edinburgh, Scotland, U.K.). This
involved performance checks on the autoclave before,
during and after the experimental programme. These were
all satisfactory. During the experiments, temperatures within
the experimental samples and in other areas of the chamber
were monitored using recently calibrated thermocouples.
After appropriate modification of the controls by an engi-
neer, the same autoclave was used to perform the gravity
displacement autoclave run on 50 mg samples of macerate
or 1 ml aliquots of 10% homogenate.
To test whether TSE infectivity survived a laboratory
cleaning and sterilization regime, 301V infected brain was
homogenized in a Griffiths tube, the homogenate was de-
canted and the empty but unwashed tube autoclaved at
136 ◦C for 1 h in a porous load autoclave. Saline (0.9% NaCl;
1 ml) was then homogenized in the tube and tested for
residual infectivity. The tube was then washed by soaking in
Decon for 2 h, washed with a tube brush, rinsed nine times
in cold water followed by continuous rinsing in running cold
water for 1 h followed by a final rinse in distilled water,
air-dried, packed in autoclavable nylon packaging (Portex;
Surgical Supply Services, Cumbernauld, North Lanarkshire,
Scotland, U.K.) and autoclaved again at 136 ◦C for 1 h; all
these steps are according to our standard laboratory proce-
dures. Again saline was homogenized in the tube and tested
for residual infectivity.
Inoculation of rodents
Samples were frozen at −20 ◦C until injection. On thawing,
saline was added to obtain a 10% (w/v) solution, based
on the original weight of the sample. Resuspension of the
samples was facilitated and transfer losses avoided by prior
placement of the samples into the Griffith tubes. The dry
heat samples were homogenized with saline to produce a
1% solution and then serially diluted 10-fold in saline. ME7
was assayed in C57BL mice, 22A and 301V in VM mice, cow
BSE in RIII mice, which were all injected intracerebrally with
20 µl of inoculum and 263K in LVG hamsters was injected
intracerebrally with 50 µl of inoculum. All injections were
performed under halothane general anaesthesia. When
clinical signs of TSE infection had developed to a standard
end point, animals were killed [13] and TSE diagnosis was
confirmed histologically.
Assessment of survival of TSE infectivity
In the experiments reported in Tables 1 and 4, titrations
were performed and titres calculated by the Karber
method [14]. In the other experiments, a single dilution
of inoculum was assayed. This approach does not allow
the direct calculation of titre in most cases. However, if
complete groups of animals succumb to the infection, the
C© 2007 Portland Press Ltd
Heat inactivation of transmissible-spongiform-encephalopathy agents 177
Table 1 Effect of 200 ◦C dry heat on TSE infectivity
Brain macerates (7–10 mg) were heated in a dry oven; then, after rehydration,
TSE infectivity was measured by titration. ME7 was assayed in C57BL mice,
301V assayed in VM mice and 263K assayed in LVG hamsters by intracerebral
injection of serial dilutions into groups of 12 animals and titres calculated from
the proportion of TSE-positive cases in each dilution by the Karber method
[14].
TSE strain Time Titre (–log ID50/g) Titre reduction
ME7 Control 8.37 –
20 min 5.35 3.02
60 min 5.31 3.06
263K Control 8.33 –
20 min 5.36 2.97
60 min 4.97 3.36
301V Control 8.33 –
20 min 6.03 2.30
60 min 5.30 3.03
dose–response curve can be used to calculate titres from
the average incubation period unless the dose–response
relationship is altered, as is often the case after heating TSE
infectivity at high temperatures. Nevertheless, the use of
such an approach is often justified, since the number of ani-
mals used is reduced. In the experiment described in Table 2,
the Poisson distribution could be used to calculate residual
titre after autoclaving [15,16], since in all but one case only
a proportion of each group succumbed to TSE infection.
Results
Exposure of TSE infectivity to 200 ◦C dry heat
To determine the effect of TSE inactivation by dry heat
treatment on TSE agents, brain samples from three TSE
models (ME7 in SV mice, 301V in VM mice and 263K in LVG
hamsters) were heated at 200 ◦C in a ‘dry heat’ oven for 20
or 60 min, rehydrated and titrated by serial dilution in mice.
Titres were reduced by approx. 3 log ID50 (infectious dose)
after heating of all three samples for 20 min (Table 1), with
little additional loss after 60 min (0–0.7 log ID50). There
was a marked prolongation of the incubation period of
heated ME7 samples compared with the same equivalent
doses in the unheated control ME7 sample, the effect
being significantly greater after 60 min than after 20 min
(Figure 1). There was only a small shift in the 263K dose–
response curve on increasing the heating time and no effect
on dose–response curves of heated 301V. The survival
properties of TSE infectivity exposed to dry heat were not
strain-specific, unlike the differences in heat-inactivation
properties observed in aqueous solution [3]. However, the
interaction with the host of the surviving subpopulation of
TSE agent was altered in a TSE strain-specific fashion.
Porous-load autoclaving of TSE infectivity
In contrast with the experimental procedure used to test the
effect of dry heat, modern autoclaving programmes are not
designed for the conduct of experimental procedures, but
are designed to optimally inactivate micro-organisms by ex-
posure to superatmospheric steam. To determine whether
TSE infectivity survived autoclaving and what parameters
affected survival within the operating range of modern hospi-
tal autoclaves and near values recommended for autoclaving
TSEs, the residual infectivity after autoclaving a 50 or 375 mg
mass of brain macerate was measured for three TSE strains,
at three temperatures and four times of exposure, giving
a total of 72 autoclaved samples. Infectivity was measured
for all samples by injection of a single dilution (10−1) of each
sample into groups of 18 mice. One sample (301V) caused
TSE infection in all recipients. All other samples resulted in
no TSE infection in any recipients or affected a proportion of
the animals in the group, suggesting that the amounts of TSE
infectivity surviving autoclaving were at or near the limits of
detection (Table 2). Because of the structure of the results
in this experiment, statistical analysis using binary logistic
regression could be performed. The numbers of TSE-posi-
tive animals were compared with the total number injected,
allowing overall trends from the data to be obtained. The
conclusions from this analysis were as follows. Some infect-
ivity was detected after autoclaving for all three strains.
Most infectivity was detected in the 301V samples. Although
least infectivity was detected in the autoclaved 22A samples,
the initial titre was lower, so the measurable clearance was
less. Statistical analysis showed that there was a significant
difference in titre reduction with respect to the strain
of agent (odds ratio 263K/22A = 7.6, 301V/22A = 44.6,
301V/263K = 5.8, P< 0.001 for all pairs). Significantly more
infectivity survived in the 375 mg samples than in the 50 mg
samples (odds ratio 3.8, P< 0.001). There was a trend
towards a small but inconsistent reduction in residual
infectivity with increasing time of exposure, but this was
not significant. There was no significant effect owing to
increasing temperature: temperature did not alter the
effectiveness of autoclaving of 263K and paradoxically
showed a slight reduction in effectiveness with increasing
temperature with 301V, although this effect too, was not
significant.
To determine whether autoclaving affected incubation
periods in this experiment, the pooled survival curves for
each TSE strain were analysed. They show that the 301V
incubation periods are much more tightly distributed than
those for the 263K and 22A strains. There was some prolon-
gation of incubation periods in the 263K samples, but only a
few incubation periods were markedly extended in the 301V
samples (Figure 2). There were some very long incubation
periods in the 22A samples, including several animals that
were clinically normal at 600 dpi (days post-injection) but
C© 2007 Portland Press Ltd
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Figure 1 Effect of 200 ◦C dry heat on TSE dose–response curves
The amount of TSE infectivity in each dilution was calculated and plotted against the incubation period of that dilution for samples before and after exposure to
dry heat for either 20 or 60 min. Linear regression lines are shown for each sample. A biphasic line has been fitted to the control ME7 sample.
Table 2 Effect of agent strain, weight of tissue, temperature and time on the survival of TSE infectivity after porous load autoclaving
Macerates of hamster brain infected with the 263K strain or VM mouse brains infected with the 301V or 22A TSE strains (with initial titres of 8.5, 8.5 and 7.0
–log ID50/g respectively) were subjected to porous load autoclaving in lumps weighing 50 or 375 mg, at 134, 136 or 138 ◦C, for 9, 18, 30 or 60 min. Samples were
resuspended in saline at a dilution of 10−1 with respect to the weight of the original brain and injected into groups of 18 hamsters or mice. TSE Pos, number of
TSE-positive animals; total, number of positive animals plus those surviving beyond the incubation period of the last positive animal in that group. The experiments
with the 263K strain were terminated at 641 dpi (days post injection), 301V at 414 dpi and 22A at 471 dpi.
301V 263K 22A
Weight (mg) Temperature ( ◦C) Time (min) TSE Pos Total TSE Pos Total TSE Pos Total
50 134 9 9 11 5 16 0 16
18 9 14 2 16 0 15
30 3 12 1 11 0 12
60 2 13 2 16 0 12
136 9 3 14 1 16 0 18
18 10 17 2 18 0 18
30 13 18 4 16 0 13
60 1 17 2 17 0 16
138 9 6 18 2 17 1 8
18 18 18 3 15 0 12
30 7 16 0 14 0 12
60 10 17 0 16 0 17
375 134 9 14 18 3 13 0 16
18 13 17 7 10 0 13
30 8 16 10 14 0 13
60 7 18 5 15 0 14
136 9 12 17 10 16 0 12
18 13 17 12 16 2 15
30 15 18 5 16 5 13
60 7 17 5 14 0 13
138 9 17 17 0 16 4 13
18 18 18 7 14 3 14
30 15 18 1 13 0 11
60 11 18 0 17 1 12
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Figure 2 Effect of TSE strain on survival of TSE infectivity
The survival of TSE-positive cases after autoclaving (Table 2) of the 301V, 263K
and 22A TSE strains is shown. (Three 22A cases were diagnosed by histological
examination only after culling at 601 dpi.)
were diagnosed as TSE-positive from their pathological
presentation.
In a separate experiment, the 22A TSE strain was
heated as a macerate (titre 7.2 ID50/g) in a hot air oven
at 160 ◦C for 1 h and then autoclaved in a porous load
autoclave at 134 ◦C for 18 min. Infectivity was detected
after hot-air heating at the 10−1 dilution (18/18 positive
for TSE infection, incubation period = 245.9 +− 6 days) and
also after subsequent autoclaving, although the amount of
infectivity was reduced (9/16 positive for TSE infection,
incubation period = 333.4 +−18.7 days).
Gravity displacement autoclaving of TSE infectivity
To determine how a typical gravity displacement autoclaving
protocol affected TSE agent inactivation properties, the resi-
dual infectivity after gravity displacement autoclaving of sam-
ples from 301V-infected brain homogenates or macerates
treated at 132 and 136 ◦C for 60, 90 or 120 min was meas-
ured (Table 3). TSE infectivity was recovered from all samples
with little difference in the numbers of cases or the average
incubation periods. More infectivity was recovered in a simi-
lar macerate sample subjected to porous-load autoclaving,
suggesting that gravity displacement may be preferable to
porous-load autoclaving.
To determine whether prolonged exposure to auto-
claving conditions at lower temperatures than normally used
during autoclaving inactivated TSE infectivity, BSE-infected
cow brain and 263K-infected hamster brain macerates were
autoclaved once or twice at 72 ◦C for 4 h and once or twice
at 134 ◦C for 18 min. The results indicate a small reduction
in titre after autoclaving BSE at 72 ◦C (Table 4). Analysis of
the dose–response curves suggests a reduction of 0.5 logs
after the first cycle and a total reduction of 0.6 logs after two
cycles for the BSE samples. Since infectivity in the 10−4 dilu-
tion was not measured and therefore an end point dilution
group was not available, the titres may have been slightly
higher than the value obtained from the Karber calculation
performed on the available data. However, comparison of
the dose–response curves of untreated and heated samples
shows no difference (results not shown), suggesting that the
calculated titres are reasonably accurate and that there may
have been a slight reduction in titre after exposure to 72 ◦C.
There was a similar small reduction estimated by incubation
period comparisons in the 263K samples.
The maximum theoretical reduction in the BSE titre
that could be measured after one autoclaving cycle at 134 ◦C
was 102.5 ID50. The actual measured reduction was 101.9 ID50
after two sequential autoclaving cycles at 134 ◦C, showing
Table 3 Gravity displacement autoclaving of 301V-infected mouse brain
Mouse brains infected with the 301V TSE strain with an initial titre of 8.5 –log ID50/g were macerated or homogenized. The macerates (50 mg) and homogenates
(1 ml of 10%) were subjected to gravity displacement autoclaving at either 132 or 136 ◦C for 60, 90 or 120 min. The macerate samples were homogenized and
made 10−2 dilution before assay in VM mice. All mice surviving beyond the last positive case in the group and diagnosed as negative for TSE infection were included
in the total. Mice were observed until culled for welfare reasons, up to 945 dpi. Mean inc., mean of incubation period.
Tissue preparation Autoclave technique Temperature ( ◦C) Time (min) TSE Pos Total Mean inc. (days) S.E.M.
Homogenate Gravity displacement 132 60 10 12 195.4 10.2
132 90 8 9 186.9 18.5
132 120 8 12 201.5 9.9
136 60 6 12 187.8 1.2
Macerate Gravity displacement 132 60 5 12 206.6 12.2
132 90 5 12 196.8 16.1
132 120 9 11 238.9 20.4
136 60 5 9 247.2 29.1
Macerate Porous load 136 60 12 12 178.2 10.0
C© 2007 Portland Press Ltd
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Table 4 Autoclaving once or twice at 72 or 134 ◦C
Macerates (340 mg) of TSE-infected cow or hamster tissue were heated in a
gravity displacement autoclave at 72 ◦C for 4 h or at 134 ◦C for 18 min. The
macerate samples were homogenized at 10−1 dilution of the original brain
sample, then subjected to serial dilution and assayed in groups of 12–18 RIII
mice for cow BSE and up to 12 hamsters for 263K.
TSE source Treatment Titre–log ID50/g Reduction in titre (log)
Cow BSE Control titration 4.8
72 ◦C
Once 4.3∗ 0.5
Twice 4.2∗ 0.6
134 ◦C
Once 2.4 2.5
Twice 3.1 1.7
263K Control titration 8.3
72 ◦C
Once 7.7∗ 0.57
Twice 7.9∗ 0.4
134 ◦C
Once 4.4 3.9
Twice 3.2 5.1
∗Titres estimated from incubation periods.
that the BSE agent can survive these conditions with
relatively small losses in titre. The first exposure to porous-
load autoclaving appeared to enhance survival of infectivity
during the second run. This result is consistent with findings
for the 263K hamster TSE model [8]. Overall the results
from these experiments show, at most, very little reduction
in titre after the exposure of BSE or 263K infectivity to
72 ◦C, even after very long exposure times. There is some
loss of infectivity after porous-load autoclaving at 134 ◦C,
but substantial amounts of infectivity could still be detected
even though the initial measurable titre of BSE was low.
Treatment with ethanol
To assess whether ethanol exposure altered TSE infectivity
survival during autoclaving, half brains from 22A-infected
VM mice were immersed in saline or ethanol for 48 h,
then either subjected to porous-load autoclaving at 134 ◦C
for 18 min or held at room temperature and then assayed
for residual TSE infectivity. Ethanol exposure at room tem-
perature had no effect on the incubation period. No infectiv-
ity was recovered in the autoclaved sample after exposure
to saline, but 17 out of 24 mice succumbed to TSE infection
after ethanol exposure, showing that ethanol provides a
degree of protection against heat inactivation during auto-
claving (Table 5).
Demonstration of survival of infectivity
on glassware
Accumulating data have suggested that TSE infectivity,
particularly from the more thermostable TSE strains, which
Table 5 Autoclaving 22A-infected brain after ethanol treatment
Two half brains, infected with the 22A TSE strain, were immersed in saline
or 70% (v/v) ethanol for 48 h at room temperature (RT; 20 ◦C). The half
brains were then irrigated for 12 h in continuously running water, then either
autoclaved at 136 ◦C for 18 min or held at room temperature. They were then
homogenized in saline at 10:1 dilution and injected intracerebrally into groups
of 12 or 24 VM mice.
Sample TSE pos Total Mean inc. (days) S.E.M.
RT
Ethanol 12 12 178 3.10
Saline 6 6 178 5.26
134 ◦C
Ethanol 17 24 274 7.86
Saline 0 20 – –
includes those derived from BSE, may not be completely
inactivated (i.e. beyond the limits of detection) by standard
autoclaving procedures. In practice, limitations to heat
sterilization of TSEs may leave surgical and laboratory
equipment contaminated with significant levels of TSE
infectivity after autoclaving. Accordingly, an experiment was
set up to test whether infectivity could be recovered from
experimental equipment typically used in TSE experiments.
301V–infected brain was homogenized and the homogenizer
washed and sterilized according to our standard laboratory
procedures. One animal was diagnosed positive for TSE
infection in the sample obtained from the homogenizer after
autoclaving on the first occasion (Table 6). The diagnosis
of this case was confirmed histologically both through the
presence of vacuolation characteristic for TSEs and by
immunostaining for TSE-specific deposition of PrP.
Discussion
Practical considerations
Autoclaves are designed to inactivate infectious organisms
by imparting heat energy directly from steam to the surface
of the sample. Heat transfer from steam is particularly effi-
cient. The simpler mode of operation is gravity displacement,
where steam is fed into the chamber, displacing the heavier
air downwards. However, pockets of air may remain in the
load. Porous-load autoclaving seeks to purge the air from
the autoclave by first evacuating the chamber, then alter-
nately pressurizing and depressurizing the chamber with
steam to displace residual air pockets. These autoclaving
regimes are highly effective for most micro-organisms. How-
ever, they may compromise inactivation of TSEs because the
agents may be dehydrated during the evacuation stage and
also may only be partially inactivated by the superatmos-
pheric waves step. The residual infectivity may be stabilized
and hence not further inactivated when the cycle progresses
to the higher target temperature. Simply increasing the
C© 2007 Portland Press Ltd
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Table 6 Recovery of TSE infectivity from a homogenizer
(a) Sterile saline was injected into VM or RIII mice. (b) Saline (1 ml) was
pipetted into a Griffith homogenizer and homogenized as for tissue. It was then
transferred to a Bijou bottle and subsequently injected into VM and RIII mice.
(c) Mouse brain was homogenized in saline, at a concentration of 10%
brain, in the same homogenizer transferred to a Bijou bottle and injected
into VM mice. (d) After autoclaving the Griffith homogenizer at 136 ◦C for
1 h, 1 ml of saline was added, homogenized as before and injected into VM
mice. (e) After draining residual fluid, the homogenizer was subjected to local
standard washing, drying, packing and re-autoclaving. Saline (1 ml) was added,
homogenized and injected into VM mice. Inc, incubation period in days.
Mouse TSE
Sample strain Pos Total Comment
Saline control (a) VM 0 23
Saline control (a) RIII 0 22
Saline wash of clean VM 0 24
homogenizer (b)
Saline wash of clean RIII 0 17
homogenizer (b)
301V Homogenate (c) VM 4 4 Average Inc = 100 days
Autoclaved (d) VM 1 24 Inc = 204 days
Autoclave + wash (e) VM 0 23
temperature e.g. from 134 to 138 ◦C, the limiting
temperature on many commercial autoclaves, or increasing
the time of exposure is unlikely to substantially increase the
degree to which TSE infectivity is inactivated.
Inactivation of TSEs by heating can sometimes be ineffi-
cient, as the results in the present paper illustrate. The re-
sults show that dry heat can stabilize some TSE infectivity
and we suggest that the initial steps of a porous-load auto-
clave operate similarly. If heat is to be used for inactivating
TSE infectivity, then conditions should be optimized to mini-
mize dehydration of the sample before and during the pro-
cedure. In addition, the rate of heating may be important –
rapid heating of the sample to the inactivation temperature
may minimize the conversion of the TSE agents into the
stabilized form [3]. The time and temperature obtained
when the run conditions are finally attained may be of less
importance if the status of the infective material has been
previously compromised. Using higher temperatures (within
the range normally achieved by hospital and laboratory
autoclaves) and/or longer run times may be of little value.
The potential for infectivity to survive a cleaning and
autoclaving regime is illustrated by the demonstration ex-
periment reported above (Table 6). Although only one
positive case was detected in this instance, the result shows
that trace amounts of TSE infectivity can survive routine
sterilization procedures, which could result in contamination
of subsequent experiments, or the infection of patients dur-
ing surgery. This result confirms the necessity of following
our standard, universal practice that has been in place for
many years, namely to only use new, unused equipment
for the preparation of all TSE materials for injection. This
policy covers post-mortem procedures to recover infected
tissue for future passage and all equipment in direct contact
with the inoculum during preparation.
Survival of infectivity
The remarkable survival of TSE infectivity under the
extreme conditions reported here has suggested to some
that normal mechanisms of inactivation of biological
molecules may not operate for TSE agents [17]. However,
we argue here that survival under even the most
extreme conditions is compatible with the properties
of biological molecules [3,18]. The results show that
small amounts of TSE infectivity can survive temperatures
that would be expected to inactivate most biological
molecules. Under optimal conditions, TSE infectivity
can be completely destroyed (to the limits of detec-
tion). For this to occur, the necessary conditions, including
the hydration status of the infectious material, the rate
of heating and the final temperature, should be optimal.
However, under suboptimal conditions, some TSE infectivity
often survives much higher temperatures, although usually
only a very small percentage of the initial titre survives.
Results from various sources show that some TSE infectivity
can become stabilized by freeze-drying and dry heat, i.e.
where the infective material becomes dehydrated; through
wet heat/high pH where the rate of heating is slow; by
exposure to organic solvents such as ethanol or where pro-
tein fixation occurs by other mechanisms; and in each case
the infectively becomes resistant to heat denaturation [8,9,
19–21]. Prior exposure to dry heat for 1 h at 160 ◦C sta-
bilizes infectivity and makes it more resistant to inactivation
by autoclaving. Collectively, these findings suggest that the
TSE agents have changed their physicochemical state so that
a subpopulation of infectivity becomes refractory to wet-
heat-inactivation processes.
Each experiment reported here can be considered on
the basis of the hypothesis that dehydration is affecting
the degree of inactivation. In the dry heat experiment
(Figure 1), the lump of brain macerate probably dehydrated
as the sample warmed up over 6–7 min to 200 ◦C. By the
time temperatures were reached at which inactivation of
hydrated infectivity takes place, a proportion of the agent
would have been stabilized by dehydration. In all the auto-
claving experiments the autoclave cycle provides a window
of opportunity for sample dehydration. In the porous-load
cycle, the autoclave chamber is first evacuated to remove
air. On reaching a target vacuum, the autoclave chamber is
alternately pressurized and depressurized with steam several
times to ensure complete removal of air and replacement
with superatmospheric steam. This results in a series of
spikes in temperature, oscillating between approximately
100 and 120 ◦C. Then more steam is introduced until the
final target temperature is reached from whence the holding
time is measured. The run is terminated by simultaneously
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switching off the steam supply and application of a vacuum to
dry the load. The surface of the tissue macerate is probably
dehydrated during the initial air evacuation stage, an
effect that would be minimized during gravity displacement
autoclaving where steam simply displaces air from the
chamber. However, gravity displacement autoclaving does
not ensure complete removal of air from the sample.
In samples exposed to ethanol, the tissue will also be
dehydrated prior to autoclaving. Further conversion into a
stabilized state may occur during the pressure spikes where
TSE agents follow a postulated stabilization reaction, rather
than a dissociation reaction on exposure to temperatures
just above the point at which heat inactivation takes place.
We have previously argued that heat denaturation
of TSE infectivity takes place biphasically with respect to
both temperature and time. TSE agents are stable at low
temperatures and remain stable until a critical temperature
is reached. Above this temperature there is a rapid loss
of infectivity with increasing temperature [3]. Above the
critical temperature, inactivation takes place rapidly, but
then reaches a plateau, so that with increasing time little
additional inactivation takes place [1,22]. There are marked
TSE strain-dependent differences in thermostability [3], and
there is up to a 3 log difference in survival between the
five TSE strains after autoclaving at 126 ◦C for 30 min [10].
Hence the denaturation pathway to inactivation involves
a TSE strain-specific molecular component of the agent.
By contrast, there was no detectable difference in the
sensitivity of the three TSE strains to dry-heat inactivation.
Once TSE agents are stabilized, the denaturation pathway to
inactivation is presumably not available. Probably destruction
of the stabilized particle occurs at significant rates only
under more extreme conditions. For example, when
autoclaving at 134–138 ◦C, most loss of infectivity probably
occurs early in the cycle. Extending the exposure times to
these high temperatures has only a small inconsistent effect
(Table 2). This effect has also been observed by others for
the 263K TSE strain autoclaved at 121 ◦C, where similar
amounts of infectivity survived after 60 and 90 min; however,
after autoclaving at 132 ◦C, residual infectivity was detected
after 60 min but not after 90 min, a difference of 0.7 log
ID50 or more [23]. It is suggested that any reduction in titre
is due to the gradual destruction of protein and nucleic acid
that occurs at these temperatures and that these processes
occur monophasically through first-order reactions.
This rationale fits with the model of the TSE agent
presented previously [1,3,10]. To account for the biphasic
heat inactivation curves, it was proposed that the TSE agent
comprised two or more discrete components. One com-
ponent need not vary between TSE models, and indeed is
likely to be the host protein PrP, present as a dimer or higher
multimers [2]. The structure of the other component(s) is
not known, but is presumed to be TSE agent-specific.
High temperature may induce a protected form of the TSE
agent, analogous to the dehydrated form. This leads to
the hypothesis that the water of solvation, i.e. the water
molecules intimately associated with the structure of the
agent, is removed or displaced, stabilizing agent structure
[1]. This hypothesis has recently gained support from
the finding that PrP, operating through the disordered
N-terminal region of the protein, can act as a nucleic acid
chaperone, promoting binding to nucleic acids and the
formation of nucleoprotein complexes [24]. Tompa and
Csermely [25] have previously argued that intrinsically
disordered proteins act as chaperones; they are highly
hydrated and can bind to structurally heterogeneous
substrates. These authors also suggested that the thermo-
dynamics of binding include a large entropic factor due to an
increase in order, which may be offset by increasing disorder
in the substrate. Iterative transitions between disorder and
order will lead to the most thermodynamically stable struc-
ture [25,26]. Such a process could operate for TSE agents,
where iterative binding of PrP to a ligand may be accelerated
by exposure to high temperatures and promote loss of the
water of hydration and greater thermostability.
Changes in incubation periods
Incubation periods for partially inactivated samples are often
longer than those for the equivalent control samples [11,12].
This property can compromise inactivation studies that rely
solely on incubation periods to measure the degree of inac-
tivation [27]. The effect is often most marked at the limiting
dilution, where many mice infected with treated samples can
have longer incubation periods than the control samples.
Prolonged incubation periods were particularly evident in
the dry heat experiment (Table 1). Some extended incub-
ation periods were also observed in the porous-load auto-
claving experiment (Table 2). Such data illustrate the
necessity to observe all animals in inactivation experiments
for extended periods to obtain reliably negative results
[28]. Presumably the conditions used in these experiments
altered the interaction between the infecting agent and
the host in some models more than others, and this
is particularly observed for the 301V/VM mouse model.
However, extended incubation periods have also been
found with 301V in other experiments (K. Fernie, D. M.
Taylor and R. A. Somerville, unpublished work). These
results suggest that there may be an intrinsic difference in
properties between TSE strains, which results in greater di-
versity of response to very small numbers of infective units.
The ME7 result in the dry heat experiment (Figure 1) may
provide an additional insight. Extended heating for 60 min
may have dehydrated the ME7 agent more greatly than after
20 min. Pathogenic mechanisms at or immediately after in-
fection may be altered. The degree to which different strains
are dehydrated may vary and hence differentially affect
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pathogenesis. It is not known what pathogenetic steps may
be affected. Possibly uptake of infectivity by the cells that
are usually susceptible does not occur after heating, but
infectivity is processed via alternative, longer cellular path-
ways. Alternatively, intracellular processing may be adver-
sely affected, delaying the initiation of replication.
Conclusion
Overall, the accumulated data demonstrate the difficulties in
destroying TSE infectivity using heat-based methods. Under
optimal conditions, where the TSE agent and its surrounding
tissue remain fully hydrated, TSE infectivity from even the
most thermostable TSE strains can be destroyed. However,
when any fixation of tissue occurs, e.g. through dehydration,
infectivity becomes much more recalcitrant to efficient
heat inactivation. In practical terms, this demonstrates
the limitations of heat-based systems (e.g. autoclaving) for
TSE sterilization. More fundamentally, these results support
the hypothesis that the hydration state of the TSE agent is
fundamental to their structural integrity.
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